VERADIGM INC (MDRX)
(Delayed Data from OTC)
$7.55 USD
-0.22 (-2.83%)
Updated May 24, 2024 03:52 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Veradigm Inc. [MDRX]
Reports for Purchase
Showing records 161 - 180 ( 600 total )
Company: Veradigm Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Comprehensive Technical and Fundamental Analysis for MDRX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Comprehensive Technical and Fundamental Analysis for MDRX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department